Log In
Print this Print this

HSV-2 vaccine (GV2207)

  Manage Alerts
Collapse Summary General Information
Company GenVec Inc.
DescriptionAdenovirus vector vaccine against herpes simplex virus type 2 (HSV-2)
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector
Latest Stage of DevelopmentPreclinical
Standard IndicationHerpes simplex virus (HSV)
Indication DetailsTreat and prevent herpes simplex virus type 2 (HSV-2) infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today